Issues related to vaccines; Issues related to 340b
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- AVENUE SOLUTIONS
- Client
- MERCK & CO. INC.
- Filing UUID
- 769ecdfe-221f-4691-a577-5f6477956acc
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Literal federal measure citations: H.R. 4299
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.